Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance
Acutaas Chemicals Ltd · Investor Presentation · 27 Oct 2026, 6:35 pm
Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance Acutaas Chemicals reported strong Q2 FY27 results, with revenue rising 42.7% YoY to ₹4,369 Mn, EBITDA surging 84.6% YoY to ₹1,760 Mn (margin expanded to 40.3%), and PAT climbing 71.4% YoY to ₹1,231 Mn. Growth was powered by Pharma Intermediates (up 53.1% YoY to ₹4,020 Mn), offsetting softness in Specialty Chemicals. Ahead of schedule, the company inaugurated its South Korea facility for semiconductor chemicals. Backed by solid visibility, management raised FY27 revenue growth guidance to ~30% and EBITDA margin guidance to 38–40%.
Original exchange filing (PDF)
More announcements from Acutaas Chemicals Ltd
- Intimation of schedule of Investor Conferences/Meets is attached · 07 Nov 2026
- Annual Sustainability Report for the financial year 2025-26 is enclosed. · 07 Nov 2026
- Transcript for Earnings call for Q2 FY 2027 Financial Results held on October 27, 2026 is attached · 02 Nov 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 is attached. · 02 Nov 2026
- Recording to earnings call held on October 27, 2026 is attached. · 27 Oct 2026
- Press Release discussing the financial results for the second quarter and half year ended as on September 30, 2026 is attached. · 27 Oct 2026
- Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 27 Oct 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 is enclosed. · 27 Oct 2026
